US Stock MarketDetailed Quotes
SRPT Sarepta Therapeutics
- 118.970
- -0.500-0.42%
Close Dec 20 16:00 ET
- 119.300
- +0.330+0.28%
Post 20:01 ET
11.36BMarket Cap77.25P/E (TTM)
121.000High118.560Low1.95MVolume119.590Open119.470Pre Close232.72MTurnover2.14%Turnover RatioLossP/E (Static)95.52MShares173.25052wk High9.31P/B10.84BFloat Cap91.34452wk Low--Dividend TTM91.15MShs Float181.830Historical High--Div YieldTTM2.04%Amplitude2.598Historical Low119.161Avg Price1Lot Size
Sarepta Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 38.37%-70.7M | 112.22%14.94M | -15.61%-242.08M | -53.99%-500.99M | 40.84%-54.66M | -76.57%-114.71M | -82.94%-122.23M | -106.96%-209.4M | 26.59%-325.35M | -215.05%-92.39M |
| Net income from continuing operations | 182.10%33.61M | 126.98%6.46M | 106.99%36.12M | 23.81%-535.98M | 141.79%45.66M | 84.12%-40.94M | 89.66%-23.94M | -392.03%-516.76M | -67.99%-703.49M | 10.44%-109.24M |
| Operating gains losses | 156.52%12.89M | 11.66%4.01M | -98.99%3.95M | 190.81%401.82M | -25.16%2.66M | -95.94%5.03M | -50.30%3.59M | 10,585.28%390.55M | 1,120.10%138.18M | 364.44%3.55M |
| Depreciation and amortization | -10.27%9.81M | -19.21%8.72M | -22.65%8.74M | 6.05%44.4M | 7.76%11.37M | 2.10%10.93M | 9.13%10.79M | 5.47%11.31M | 10.12%41.86M | 4.02%10.55M |
| Other non cash items | 3,220.58%56.78M | 101.09%1.11M | 431.01%10.43M | -866.48%-96.81M | -86.78%950K | 73.25%1.71M | -16,700.82%-101.43M | -48.92%1.96M | 113.45%12.63M | 16.48%7.19M |
| Change In working capital | -40.02%-216.62M | 3.51%-45.38M | -155.40%-329.61M | -1,118.87%-481.09M | -192.43%-150.29M | -1,649.29%-154.71M | -203.47%-47.03M | -196.56%-129.06M | 59.79%-39.47M | -211.98%-51.39M |
| -Change in receivables | 9.17%-74.53M | 245.00%18.81M | 333.72%21.52M | -201.27%-185.7M | -521.02%-81.47M | -3,598.81%-82.05M | 49.45%-12.97M | 63.47%-9.21M | -19.34%-61.64M | -309.58%-13.12M |
| -Change in inventory | -165.06%-70.54M | -283.86%-102.46M | -19,675.16%-60.51M | -190.89%-147.71M | -959.73%-94.1M | -0.29%-26.61M | -150.00%-26.69M | 93.47%-306K | 39.38%-50.78M | 67.43%-8.88M |
| -Change in prepaid assets | -593.94%-32.2M | -758.21%-58.3M | -1,839.38%-145.05M | ---- | ---- | --6.52M | --8.86M | ---7.48M | ---- | ---- |
| -Change in payables and accrued expense | 109.60%1.69M | 396.97%77.59M | -37.46%-92.84M | -133.97%-50.14M | 374.36%61.09M | -133.00%-17.55M | -130.20%-26.13M | -1,244.90%-67.54M | 533.44%147.57M | -81.55%12.88M |
| -Change in other current assets | -267.38%-46.01M | -72.19%8.94M | 89.72%-2.32M | -173.28%-10.71M | 60.43%-7.83M | -460.17%-12.52M | 83.53%32.15M | -268.02%-22.52M | -85.83%14.62M | -168.09%-19.78M |
| -Change in other working capital | 122.07%4.97M | 145.11%10.04M | -129.11%-50.42M | 2.71%-86.83M | 10.74%-20.08M | 0.00%-22.5M | 0.00%-22.25M | 0.00%-22.01M | 0.00%-89.24M | 0.00%-22.49M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 38.37%-70.7M | 112.22%14.94M | -15.61%-242.08M | -53.99%-500.99M | 40.84%-54.66M | -76.57%-114.71M | -82.94%-122.23M | -106.96%-209.4M | 26.59%-325.35M | -215.05%-92.39M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 38.82%-128.83M | -201.96%-98.53M | 1,651.49%218.8M | 84.16%-165.8M | -756.98%-64.36M | -1,201.37%-210.57M | 133.32%96.63M | 101.59%12.49M | -311.32%-1.05B | 480.13%9.8M |
| Net PPE purchase and sale | -25.58%-37.26M | -62.86%-29.17M | -242.06%-32.44M | -146.91%-76.11M | -139.06%-19.04M | -260.50%-29.67M | -97.28%-17.91M | -70.87%-9.49M | 19.92%-30.82M | -261.02%-7.96M |
| Net intangibles purchase and sale | --0 | --0 | -10,538.30%-10M | -687.60%-11.24M | --0 | ---11.1M | ---45K | ---94K | 38.20%-1.43M | ---202K |
| Net investment purchase and sale | 46.08%-91.56M | -651.01%-69.36M | 1,083.63%261.24M | 82.21%-180.46M | -352.30%-45.32M | -709.53%-169.8M | 104.48%12.59M | 102.83%22.07M | -333.67%-1.01B | 1,097.89%17.96M |
| Net other investing changes | ---- | ---- | ---- | --102M | --0 | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 38.82%-128.83M | -201.96%-98.53M | 1,651.49%218.8M | 84.16%-165.8M | -756.98%-64.36M | -1,201.37%-210.57M | 133.32%96.63M | 101.59%12.49M | -311.32%-1.05B | 480.13%9.8M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -10.70%13.76M | 581.08%39.92M | -78.25%22.14M | -46.24%125M | -81.92%1.94M | -92.88%15.41M | 1,628.91%5.86M | 1,939.98%101.8M | -58.60%232.51M | -98.04%10.75M |
| Net issuance payments of debt | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --304.17M | --0 |
| Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Proceeds from stock option exercised by employees | -10.70%13.76M | 581.08%39.92M | -79.63%22.14M | 285.91%131.89M | -82.81%1.94M | 117.59%15.41M | 1,628.91%5.86M | 2,078.00%108.68M | -441.05%-70.95M | 426.21%11.3M |
| Net other financing activities | ---- | ---- | ---- | -861.87%-6.89M | --0 | --0 | --0 | ---6.89M | 90.78%-716K | 61.31%-554K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -10.70%13.76M | 581.08%39.92M | -78.25%22.14M | -46.24%125M | -81.92%1.94M | -92.88%15.41M | 1,628.91%5.86M | 1,939.98%101.8M | -58.60%232.51M | -98.04%10.75M |
| Net cash flow | ||||||||||
| Beginning cash position | -54.17%399.2M | -50.28%442.87M | -54.96%444.01M | -53.62%985.8M | -46.95%561.08M | -1.82%870.95M | -28.37%890.69M | -53.62%985.8M | 40.60%2.13B | -34.23%1.06B |
| Current changes in cash | 40.05%-185.77M | -121.23%-43.67M | 98.80%-1.14M | 52.46%-541.79M | -62.95%-117.07M | -281.65%-309.87M | 94.46%-19.74M | 89.22%-95.11M | -285.68%-1.14B | -113.89%-71.85M |
| End cash Position | -61.96%213.43M | -54.17%399.2M | -50.28%442.87M | -54.96%444.01M | -54.96%444.01M | -46.95%561.08M | -1.82%870.95M | -28.37%890.69M | -53.62%985.8M | -53.62%985.8M |
| Free cash flow | 30.56%-107.96M | 89.85%-14.23M | -29.93%-284.52M | -64.53%-588.34M | 26.71%-73.7M | -108.92%-155.48M | -84.72%-140.19M | -105.17%-218.98M | 26.11%-357.6M | -197.15%-100.56M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data